Coronado gets $25.8 million boost to pursue parasite-based autoimmune disease therapy
08 July 2011
Donna Young
Please Login to read the full article.
08 July 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- GEMINI programme provides first boost for Takeda's vedolizumab in ulcerative colitis
- US FDA warns public of fraudulent stem cell schemes
- US FDA panel backs Remicade use for ulcerative colitis in children
- FDA seeks panel advice on aptness of adult Remicade data in peds for colitis
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
